Martin Brenner - 29 Aug 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Scientific Officer
Signature
/s/ Martin Brenner
Issuer symbol
IBIO
Transactions as of
29 Aug 2022
Net transactions value
$0
Form type
4
Filing time
31 Aug 2022, 16:00:46 UTC
Previous filing
25 Aug 2021
Next filing
15 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +700,000 $0.000000 700,000 29 Aug 2022 Common Stock 700,000 $0.2800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.